Project Description
USA FDA ICH Preclinical Contract Research Organization needed to conduct preclinical studies to support a Phase 1 IND filign for a new drug. We need genotoxicity, mutagenicity, repeat dose toxicology in 2 species (rodent and nonrodent) with toxicokinetics and histopathology, and safety pharmacology to support a chronic long-term use in human patients.
Project Information
Number:10-01936